Breast Cancer : Drugs
Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
Drugs could include:
 |
Breast cancer is the abnormal growth and uncontrolled division of cells in the breast. Cancer cells invade and destroy surrounding normal tissue, and can spread throughout the body via blood or lymph fluid (clear fluid bathing body cells) to start...
|
 |
Breast cancer is caused by the development of malignant cells in the breast. The malignant cells originate in the lining of the milk glands or ducts of the breast (ductal epithelium), defining this malignancy as a cancer. Cancer cells are characte...
|
 |
Breast cancer is the abnormal growth and uncontrolled division of cells in the breast. Cancer cells can invade and destroy surrounding tissue, and may metastasize (spread) throughout the body via blood or lymph fluid to other parts of the body.
|
|
Doxorubicin is a cancer (antineoplastic) medication. Doxorubicin interferes with the
growth of cancer cells and slows their growth and spread in the body.
|
|
Fluorouracil is a cancer (antineoplastic) medication. Fluorouracil interferes with the growth
of cancer cells and slows their growth and spread in the body.
|
|
Anastrozole lowers estrogen levels in postmenopausal women, which may slow the
growth of certain types of breast tumors that need estrogen to grow in the body.
|
|
Antineoplastic agent; selective aromatase inhibitor.
|
|
Exemestane lowers estrogen levels in postmenopausal women, which may slow the
growth of certain types of breast tumors that need estrogen to grow in the body.
|
|
Capecitabine (brand name Xeloda) is a drug that interferes with the growth of cancer cells. Purpose Capecitabine is used to treat breast cancer and cancer of the colon and rectum (colorectal cancer) that have spread to other parts of the body (metastasized).
|
|
Antineoplastic agent; prodrug of fluorouracil (an antimetabolite).
|
|
Antineoplastic agent and immunosuppressant; nitrogen mustard-derivative alkylating agent.
|
|
Cyclophosphamide is an anticancer (antineoplastic) agent. It also acts as a suppressor of the immune system.
|
|
Cyclophosphamide is a cancer (chemotherapeutic) medication. Cyclophosphamide interferes
with the growth of cancer cells and slows their growth and spread in the body.
|
|
Semisynthetic taxoid; an antineoplastic agent.
|
|
Docetaxel is a drug used to treat certain types of cancer. Docetaxel is available under the trade name Taxotere.
|
|
Antineoplastic agent; anthracycline glycoside antibiotic.
|
|
Doxorubicin, which kills cancer cells, is among the most widely used chemotherapy drugs. It is also known by its trade name, Adriamycin.
|
|
Epirubicin is a cancer medication that interferes with the growth of cancer cells and slows
their growth and spread in the body.
|
|
Epirubicin is a semi-synthetic anthracycline-based anticancer (or antineoplastic) drug derived from doxorubicin . It is also known by its trade name Ellence.
|
|
Anthracycline glycoside antineoplastic antibiotic; the 4′-epimer of doxorubicin; a semisynthetic derivative of daunorubicin.
|
|
Antineoplastic agent; irreversible, selective steroidal aromatase inhibitor (type I), structurally related to the natural substrate androstenedione.
|
|
Fluorouracil is a medication that kills cancer cells. It is also known as 5-FU or 5-fluourouracil, and as the brand name Adrucil.
|
|
Pyrimidine antagonist; antimetabolite; antineoplastic agent.
|
|
Fulvestrant blocks the actions of estrogen in the body. Certain types of breast cancer require
estrogen to grow.
|
|
Antineoplastic agent; estrogen antagonist.
|
|
Antimetabolite antineoplastic agent; a synthetic pyrimidine nucleoside.
|
|
Gemcitabine is a drug that is used to treat advanced stages of pancreatic, lung, and other cancers. Its brand name is Gemzar.
|
|
Gemcitabine is a cancer medication that interferes with the growth and spread of cancer
cells in the body.
|
|
Lapatinib is a cancer medication.
|
|
Antineoplastic agent; inhibitor of HER1 and HER2 tyrosine kinases.
|
|
Letrozole lowers estrogen levels in postmenopausal women, which may slow the growth
of certain types of breast tumors that need estrogen to grow in the body.
|
|
Antineoplastic agent; selective aromatase inhibitor.
|
|
Antineoplastic agent and immunosuppressant; folic acid antagonist.
|
|
Methotrexate is a folic acid derivative that interferes with folic acid metabolism (folate antagonist). It is a cytotoxic agent (a chemical that is directly toxic to cells) with multiple characteristics and may be described as an antimetabolite, antineoplastic, and immunosuppressant.
|
|
Methotrexate injection interferes with the growth of certain cells of the body, especially
cells that reproduce quickly, such as cancer cells, bone marrow cells, and skin cells.
|
|
Paclitaxel is a cancer medication that interferes with the growth of cancer cells and slows
their growth and spread in the body.
|
|
Paclitaxel is a drug used to treat certain types of cancer. Paclitaxel is available under the trade name Taxol.
|
|
Antineoplastic agent; natural or semisynthetic diterpene from the bark of the Western (Pacific) yew ( Taxus brevifolia ) or needles and twigs of Taxus baccata .
|
|
Paclitaxel protein-bound is a cancer (antineoplastic) medication. Paclitaxel protein-bound
interferes with the growth of cancer cells and slows their growth and spread in the body.
|
|
Tamoxifen (also known as Nolvadex) is a synthetic compound similar to estrogen. It mimics the action of estrogen on the bones and uterus, but blocks the effects of estrogen on breast tissue.
|
|
A nonsteroidal estrogen agonist-antagonist; an antineoplastic agent.
|
|
Tamoxifen, a selective estrogen-receptor modulator, is an oral medication exhibiting both estrogen agonist and antagonist effects. Tamoxifen can be used to treat advanced breast cancer, to decrease the risk of recurrence of early-stage breast cancer, and for breast cancer prevention.
|
|
Tamoxifen blocks the actions of estrogen, a female hormone. Certain types of breast
cancer require estrogen to grow.
|
|
Docetaxel is a cancer medicine that slows the growth and spread of cancer cells in the
body.
|
|
Toremifene blocks estrogen from reaching cancer cells. Certain types of breast cancer require
estrogen to grow.
|
|
Toremifene, also known as Fareston, is a synthetic compound similar to estrogen. It mimics the action of estrogen on the bones and uterus, but blocks the effects of estrogen on breast tissue.
|
|
Antineoplastic agent; a nonsteroidal estrogen agonist-antagonist that is structurally and pharmacologically related to tamoxifen.
|
|
Trastuzumab is a cancer medication. It interferes with the growth of cancer cells and
slows their growth and spread in your body.
|
|
Trastuzumab is a humanized monoclonal antibody produced by recombinant DNA technology that binds specifically to the human epidermal growth factor receptor 2 protein (also known as HER2 or neu or c-erb-2) that is found on the cell surface of some cancer tumors, most notably breast cancer . The drug is marketed in the United States under the Herceptin brand name.
|
|
Antineoplastic agent; a recombinant DNA-derived humanized anti-HER2 monoclonal antibody.
|
|
Methotrexate interferes with the growth of certain cells of the body, especially cells that
reproduce quickly, such as cancer cells, bone marrow cells, and skin cells.
|
|
Vinorelbine is an antineoplastic medication. Vinorelbine interferes with the growth of cancer
cells and slows their growth and spread in the body.
|
|
Vinorelbine is a drug used to treat certain types of cancer. Vinorelbine is available under the trade name Navelbine.
|
|
Antineoplastic agent; semisynthetic vinca alkaloid.
|
|
Capecitabine is a cancer (chemotherapeutic) medication. Capecitabine interferes with the
growth of cancer cells and slows their growth and spread in the body.
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.